Spectrawave
Spectrawave: Innovating optical diagnostic and therapeutic devices for enhanced cardiovascular care.
Founded
2017Spectrawave: Innovating optical diagnostic and therapeutic devices for enhanced cardiovascular care.
Spectrawave, founded in Waltham, Massachusetts, is a medical device company dedicated to advancing cardiovascular care through innovative optical diagnostic and therapeutic devices. Their core mission is to enhance the diagnosis and treatment of cardiovascular diseases. Spectrawave's flagship product, the HyperVue Imaging System, integrates next-generation DeepOCT™ with NIRS technology to provide high-resolution intravascular imaging, aiding in clinical decision-making by evaluating morphology, lipid content, optimizing landing zones, determining stent sizing, and assessing post-PCI outcomes.
Notable individuals affiliated with Spectrawave include experts in medical device development and cardiovascular health. The company has garnered attention from prominent investors in the medical technology sector. Key achievements include the successful development and deployment of the HyperVue Imaging System, which has significantly improved workflow efficiency and diagnostic accuracy in cath labs. Spectrawave's impact on cardiovascular care is marked by its commitment to providing powerful imaging solutions that support better clinical outcomes and patient care.
Companies similar to Spectrawave include HyperMed Imaging, WaveDyn Vision, FastWave Medical and Physiowave.
Spectrawave was founded in 2017.
Spectrawave's headquarters is located in Waltham, MA, US.
Spectrawave's most recent funding round was for $13.2M (USD) in February 2021.
As of Feb 3, 2021, Spectrawave has disclosed funding of $29.6M (USD). Undisclosed round amounts are excluded.
Spectrawave has 43 employees as of Feb 5, 2024.
Physiowave
physiowave.com
